CHANGJIANG PHARMACEUTICAL GROUP CO., LTD.

Andere talen Changjiang Pharmaceutical Group Co., Ltd.

Aandelen

300391

CNE100001XN8

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,05 ^CNY	-5,15%		+2,02%	-47,67%

29/04	Changjiang Pharmaceutical Group Co, Ltd. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
29/04	Changjiang Pharmaceutical Group Co, Ltd. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma	09/04
Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps	01/04
YiChang HEC ChangJiang Pharmaceutical's Profit Surges in 2023	29/03
Yichang Hec Changjiang Pharmaceutical Expects Up to 2,627% Profit Surge in 2023	13/03
HEC ChangJiang Pharmaceutical Increases Transaction Limits Under 2 Contracts	08/11
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24-10-23
HEC ChangJiang Pharmaceutical's Insulin Injection Cleared for Market Launch in China	26-09-23
HEC ChangJiang Pharmaceutical Returns to Profit on Surge in Anti-Viral Drug Sales	01-09-23
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	22-08-23
China Greenlights New Drug Application for HEC ChangJiang Pharmaceutical's Hepatitis C Drug	16-08-23
HEC ChangJiang Pharmaceutical Forecasts Surge in H1 Profit; Shares Rise 5%	27-07-23
Yucong Tianshun No. 2 Private Equity Securities Investment Fund managed by Shanghai Yucong Asset Management Co., Ltd completed the acquisition of 5.9942% stake in Changjiang Pharmaceutical Group Co., Ltd. from Changxing Shengshi Fenghua Business Co., Ltd.	25-07-23
HEC ChangJiang Pharma Repurchases $400 Million Convertible Bonds Issued to Blackstone	06-07-23
Yucong Tianshun No. 2 Private Equity Securities Investment Fund managed by Shanghai Yucong Asset Management Co., Ltd signed Share Transfer Agreement to acquire 5.9942% stake in Changjiang Pharmaceutical Group Co., Ltd. from Changxing Shengshi Fenghua Business Co., Ltd. for CNY 154.14 million.	15-06-23
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27-04-23
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27-04-23
Changjiang Pharma Units Sign 359 Million Yuan Contracts	17-04-23
YiChang HEC ChangJiang Pharma to Return to Profitability	20-03-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Changjiang Pharmaceutical Group Co., Ltd.

Aandelen

300391

CNE100001XN8

Andere talen

Filters